Cargando…
Plasmodium vivax and Plasmodium falciparum ex vivo susceptibility to anti-malarials and gene characterization in Rondônia, West Amazon, Brazil
BACKGROUND: Chloroquine (CQ), a cost effective antimalarial drug with a relatively good safety profile and therapeutic index, is no longer used by itself to treat patients with Plasmodium falciparum due to CQ-resistant strains. P. vivax, representing over 90% of malaria cases in Brazil, despite repo...
Autores principales: | Aguiar, Anna Caroline C, Pereira, Dhelio B, Amaral, Nayra S, De Marco, Luiz, Krettli, Antoniana U |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945814/ https://www.ncbi.nlm.nih.gov/pubmed/24581308 http://dx.doi.org/10.1186/1475-2875-13-73 |
Ejemplares similares
-
THE CULTIVATION OF MALARIAL PLASMODIA (PLASMODIUM VIVAX AND PLASMODIUM FALCIPARUM) IN VITRO
por: Bass, C. C., et al.
Publicado: (1912) -
Natural Plasmodium infection in monkeys in the state of Rondônia (Brazilian Western Amazon)
por: Araújo, Maisa S, et al.
Publicado: (2013) -
Drug resistance and population structure of Plasmodium falciparum and Plasmodium vivax in the Peruvian Amazon
por: Villena, Fredy E., et al.
Publicado: (2022) -
Commercial drugs containing flavonoids are active in mice with
malaria and in vitro against chloroquine-resistant
Plasmodium falciparum
por: Penna-Coutinho, Julia, et al.
Publicado: (2018) -
Proteomic Analysis of Urine from Patients with Plasmodium vivax Malaria Unravels a Unique Plasmodium vivax Protein That Is Absent from Plasmodium falciparum
por: Fantin, Raianna F., et al.
Publicado: (2022)